{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:15:39Z","timestamp":1791404139949,"version":"4.3.3"},"reference-count":38,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1001.020714","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T15:10:44Z","timestamp":1336749044000},"page":"109-116","source":"Crossref","is-referenced-by-count":92,"title":["Respiratory and Urinary Tract Infections, Arthritis, and Asthma Associated with HTLV-I and HTLV-II Infection"],"prefix":"10.3201","volume":"10","author":[{"given":"Edward L.","family":"Murphy","sequence":"first","affiliation":[{"name":"University of California San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Westat, Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Sacher","sequence":"additional","affiliation":[{"name":"Hoxworth Blood Center, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Fridey","sequence":"additional","affiliation":[{"name":"Blood Bank of San Bernardino and Riverside Counties, San Bernardino, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Smith","sequence":"additional","affiliation":[{"name":"Oklahoma Blood Institute, Oklahoma City, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharie C.","family":"Nass","sequence":"additional","affiliation":[{"name":"American Red Cross Blood Services Chesapeake and Potomac, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Newman","sequence":"additional","affiliation":[{"name":"American Red Cross Blood Services Southeastern Michigan, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Ownby","sequence":"additional","affiliation":[{"name":"American Red Cross Blood Services Southeastern Michigan, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Garratty","sequence":"additional","affiliation":[{"name":"American Red Cross Blood Services Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila T.","family":"Hutching","sequence":"additional","affiliation":[{"name":"American Red Cross Blood Services Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Westat, Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2004,1]]},"reference":[{"key":"key-10.3201\/eid1001.020714-201205110400-R1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1101\/gr.9.6.525","article-title":"Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T\u2011cell leukemia\/lymphotropic viruses.","volume":"9","author":"Slattery","year":"1999","journal-title":"Genome Res"},{"key":"key-10.3201\/eid1001.020714-201205110400-R2","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","article-title":"Human T\u2011lymphotropic virus type I infection.","volume":"353","author":"Manns","year":"1999","journal-title":"Lancet"},{"key":"key-10.3201\/eid1001.020714-201205110400-R3","first-page":"19","article-title":"Counseling and medical evaluation of HTLV-I- and HTLV-II-infected patients.","volume":"\u25fc\u25fc\u25fc","author":"Gebretsadik","year":"1993-94","journal-title":"AIDS Clin Rev"},{"key":"key-10.3201\/eid1001.020714-201205110400-R4","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1097\/00042560-199600001-00031","article-title":"Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection.","volume":"13","author":"Hall","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key-10.3201\/eid1001.020714-201205110400-R5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.48.2.315","article-title":"HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II infected blood donors.","volume":"48","author":"Murphy","year":"1997","journal-title":"Neurology"},{"key":"key-10.3201\/eid1001.020714-201205110400-R6","first-page":"233","article-title":"Cavitating Pneumocystis pneumonia in an autopsied case of adult T\u2011cell leukemia.","volume":"56","author":"Marutsuka","year":"1992","journal-title":"Int J Hematol"},{"key":"key-10.3201\/eid1001.020714-201205110400-R7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/infdis\/169.3.692","article-title":"Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.","volume":"169","author":"Robinson","year":"1994","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1001.020714-201205110400-R8","first-page":"582","article-title":"HTLV-1 uveitis (HU).","volume":"11","author":"Watanabe","year":"1997","journal-title":"Leukemia"},{"key":"key-10.3201\/eid1001.020714-201205110400-R9","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/S0140-6736(87)91362-6","article-title":"T-lymphocyte alveolitis in HTLV-I-associated myelopathy.","volume":"2","author":"Sugimoto","year":"1987","journal-title":"Lancet"},{"key":"key-10.3201\/eid1001.020714-201205110400-R10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4269\/ajtmh.1993.48.170","article-title":"Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.","volume":"48","author":"Mita","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid1001.020714-201205110400-R11","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1097\/00042560-199600001-00011","article-title":"HTLV-I arthropathy and Sjogren syndrome.","volume":"13","author":"Nishioka","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key-10.3201\/eid1001.020714-201205110400-R12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0025-7125(05)70514-9","article-title":"Arthritis syndromes associated with human T cell lymphotropic virus type I infection.","volume":"81","author":"McCallum","year":"1997","journal-title":"Med Clin North Am"},{"key":"key-10.3201\/eid1001.020714-201205110400-R13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/infdis\/173.3.584","article-title":"Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki","volume":"173","author":"Stuver","year":"1996","journal-title":"Jpn J Infect Dis"},{"key":"key-10.3201\/eid1001.020714-201205110400-R14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/(SICI)1097-0215(19960703)67:1<35::AID-IJC8>3.0.CO;2-0","article-title":"HCV infection and liver cancer mortality in a Japanese population with HTLV-I.","volume":"67","author":"Stuver","year":"1996","journal-title":"Int J Cancer"},{"key":"key-10.3201\/eid1001.020714-201205110400-R15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00042560-199711010-00005","article-title":"Are HTLV-II-seropositive injection drug users at increased risk for bacterial pneumonia, abscess and lymphadenopathy?","volume":"16","author":"Modahl","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key-10.3201\/eid1001.020714-201205110400-R16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1086\/514143","article-title":"Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.","volume":"176","author":"Murphy","year":"1997","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1001.020714-201205110400-R17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/archinte.159.13.1485","article-title":"Increased incidence of infectious diseases and neurologic abnormalities during prospective follow-up of HTLV-II and -I infected blood donors.","volume":"159","author":"Murphy","year":"1999","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid1001.020714-201205110400-R18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1182\/blood.V83.4.1143.1143","article-title":"Accuracy of supplementary serologic testing for human T\u2011lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.","volume":"83","author":"Busch","year":"1994","journal-title":"Blood"},{"key":"key-10.3201\/eid1001.020714-201205110400-R19","unstructured":"SAS Institute, Inc. SAS\/STAT(r) user\u2019s guide, version 8, Cary, NC: SAS Institute Inc.; 1999."},{"key":"key-10.3201\/eid1001.020714-201205110400-R20","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1001\/jama.255.22.3133","article-title":"Prevalence of antibodies to HTLV\u2011I, \u2011II, and \u2011III in intravenous drug abusers from an AIDS endemic region.","volume":"255","author":"Robert\u2011Guroff","year":"1986","journal-title":"JAMA"},{"key":"key-10.3201\/eid1001.020714-201205110400-R21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/320879","article-title":"Risk factors for skin and soft\u2011tissue abscesses among injection drug users: a case\u2011control study.","volume":"33","author":"Murphy","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1001.020714-201205110400-R22","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","article-title":"Infective dermatitis of Jamaican children: a marker for HTLV-I infection.","volume":"336","author":"LaGrenade","year":"1990","journal-title":"Lancet"},{"key":"key-10.3201\/eid1001.020714-201205110400-R23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00042560-200008150-00014","article-title":"HTLV-II and bacterial infections among injection drug users.","volume":"24","author":"Safaeian","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.3201\/eid1001.020714-201205110400-R24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/clinids\/23.1.138","article-title":"Infectious complications of human T cell leukemia\/lymphoma virus type I infection.","volume":"23","author":"Marsh","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1001.020714-201205110400-R25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1006\/viro.1995.1360","article-title":"In vivo cellular tropism of human T\u2011lymphotropic virus type II is not restricted to CD8+ cells.","volume":"210","author":"Lal","year":"1995","journal-title":"Virology"},{"key":"key-10.3201\/eid1001.020714-201205110400-R26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1089\/088922201750461339","article-title":"Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle\u2011aged HTLV-I- and -II-infected U.S. cohorts.","volume":"17","author":"Murphy","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key-10.3201\/eid1001.020714-201205110400-R27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0090-1229(92)90147-G","article-title":"Lymphocyte subsets in HTLV-II-infected former blood donors: relationship to spontaneous lymphocyte proliferation.","volume":"65","author":"Prince","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"key-10.3201\/eid1001.020714-201205110400-R28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00002030-199303000-00004","article-title":"Effects of retroviral infections on immune function in African\u2011American intravenous drug users.","volume":"7","author":"Klimas","year":"1993","journal-title":"AIDS"},{"key":"key-10.3201\/eid1001.020714-201205110400-R29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V76.2.409.bloodjournal762409","article-title":"A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users.","volume":"76","author":"Rosenblatt","year":"1990","journal-title":"Blood"},{"key":"key-10.3201\/eid1001.020714-201205110400-R30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood.V99.1.224","article-title":"Human T-cell leukemia virus type 2 induces survival and proliferation of CD34(+) TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor.","volume":"99","author":"Bovolenta","year":"2002","journal-title":"Blood"},{"key":"key-10.3201\/eid1001.020714-201205110400-R31","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.4049\/jimmunol.165.7.4127","article-title":"Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II\/HIV-1 coinfected individuals.","volume":"165","author":"Lewis","year":"2000","journal-title":"J Immunol"},{"key":"key-10.3201\/eid1001.020714-201205110400-R32","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1128\/JVI.72.9.7664-7668.1998","article-title":"Bet al. Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte\/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathy.","volume":"72","author":"Zehender","year":"1998","journal-title":"J Virol"},{"key":"key-10.3201\/eid1001.020714-201205110400-R33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/infdis\/173.3.584","article-title":"Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki","volume":"173","author":"Stuver","year":"1996","journal-title":"Jpn J Infect Dis"},{"key":"key-10.3201\/eid1001.020714-201205110400-R34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"key-10.3201\/eid1001.020714-201205110400-R35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity.","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"key-10.3201\/eid1001.020714-201205110400-R36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections: disease panorama and challenges.","volume":"183","author":"Stamm","year":"2001","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1001.020714-201205110400-R37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/(SICI)1097-0215(19960703)67:1<35::AID-IJC8>3.0.CO;2-0","article-title":"HCV infection and liver cancer mortality in a Japanese population with HTLV-I.","volume":"67","author":"Stuver","year":"1996","journal-title":"Int J Cancer"},{"key":"key-10.3201\/eid1001.020714-201205110400-R38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/315177","article-title":"A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki","volume":"181","author":"Boschi\u2011Pinto","year":"2000","journal-title":"Jpn J Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/10\/1\/02-0714_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T21:46:52Z","timestamp":1732571212000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/10\/1\/02-0714_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,1]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1001.020714","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}